Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Gurney, Howard (Primary Chief Investigator)
Chapman, Nicola (Research Coordinator)
Butala, Radhika (Research Coordinator)

Faculty of Medicine, Health and Human Sciences

Project: Other

Acronym	KEYNOTE-641
Status	Active
Effective start/end date	8/08/19 → 5/06/24